共 486 条
[31]
Andrade SE(2015)Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis Breast Cancer Res Treat 149 255-1684
[32]
Li DK(2018)Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact Breast Cancer Res Treat 34 3308-1672
[33]
Nekhlyudov L(2016)Subtype-dependent relationship between young age at diagnosis and breast cancer survival J Clin Oncol 353 1673-3752
[34]
Raebel MA(2005)Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1659-1439
[35]
Ritzwoller DP(2005)Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 32 3744-1834
[36]
Partridge AH(2014)Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831 J Clin Oncol 21 1431-346
[37]
Pawloski PA(2003)Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 J Clin Oncol 373 1824-264
[38]
Toh S(2018)Neonatal outcomes of pregnancy-associated breast cancer: population-based study on 11 million births Breast J 19 337-359
[39]
Middleton LP(2015)Pediatric outcome after maternal cancer diagnosed during pregnancy N Engl J Med 13 256-284
[40]
Amin M(2018)Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients Lancet Oncol 9 355-236